Migrén: vizsgálatok itt: Hollandia

7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  Where

  Nijmegen, 's-Gravenhage

  Életkor

  12 év to 17 év

  People

  420 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06810505 · EU 2024-513836-28-00
• 3. fázisTaking people
  A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

  Where

  Amsterdam, Nijmegen, 's-Gravenhage, Terneuzen

  Életkor

  6 év to 17 év

  People

  450 worldwide

  Run by

  AbbVie

  See details and how to joinNCT05711394 · EU 2022-501100-94-00
• No phaseTaking people
  The RECLAIM Study.

  Where

  Nieuwegein, Rotterdam

  Életkor

  18 év to 84 év

  People

  110 worldwide

  Run by

  Salvia BioElectronics

  See details and how to joinNCT06450444
• 3. fázisTaking people
  A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

  Where

  Leiden, Nijmegen, Zwolle

  Életkor

  18 év to 45 év

  People

  723 worldwide

  Run by

  Pfizer

  See details and how to joinNCT06641466 · EU 2024-517121-10-00
• 4. fázisTaking people
  (WHAT!) – RCT: Open-label randomized controlled trial for the effects of continuous daily use of ethinylestradiol/levonorgestrel (30/150 µg/day) compared with vitamin E (400 IU/day) in the treatment of menstrually-related migraine and perimenopausal migraine

  Where

  Leiden

  Életkor

  18 év to 64 év

  People

  360

  Run by

  Leids Universitair Medisch Centrum (LUMC)

  See details and how to joinNCT04007874 · EU 2024-517127-40-00
• 1. fázisNot yet taking people in Hollandia
  Oxytocine and migraine

  Where

  Rotterdam

  Életkor

  18 év to 64 év

  People

  30

  Run by

  Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

  See details and how to join2023-504690-21-00 · EU 2023-504690-21-00
• 3. fázisCsak meghívásos
  Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

  Where

  Amsterdam, Nijmegen, 's-Gravenhage, Terneuzen

  Életkor

  6 év to 17 év

  People

  650 worldwide

  Run by

  AbbVie

  See details and how to joinNCT05707949 · EU 2022-501099-24-00